With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...

Bristol Myers Squibb said it has received positive results for its latest lymphoma treatment trials, the fifth type of cancer the drug has been shown to treat.

A devoted son has given his father a new kidney after his organ function declined following chemotherapy treatment 10 years ...

"Full House" actress and friend Candace Cameron Bure gave an update on former co-star Dave Coulier's cancer treatment.

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

The Twin Harbors community is rallying around a beloved Little League coach as he fights a cancer diagnosis. Steve Bove, who has long been associated as a coach and former president and supporter of ...

BREAKING NEWS: Blues sign 12-year old Carter Johnson to a 1-day contract. Carter, who grew up playing hockey in Nebraska, was ...

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

Tea planter Vishal Mahindra was twice diagnosed with non-Hodgkin's lymphoma, a type of blood cancer that develops in the ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

The committee reviewed data showing a 94 percent complete response rate as a third- or later-line treatment for refractory follicular lymphoma.